Tradestie Institutional Equity Comparison Engine

BOLD vs IMMX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BOLD Overall Edge

BOLD Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Momentum & Technical, Options & Structure while IMMX counters with relative strength in Growth & Margin. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMMX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IMMX sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BOLD N/M vs IMMX N/M Fwd P/E
Growth & Margin Winner IMMX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner BOLD
1Y +101.7% vs +64.5% ยท 52W Pos 62% vs 28%
Options & Structure Winner BOLD
UNCLASSIFIED (N/A IV) vs BREAKDOWN (30th %ile IV)
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0
IMMX NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$6.96
-1.14% 1D
Market Cap $590.0M
1M Return -16.65%
1Y Return +64.54%
Forward P/E N/M
Unified AI Score
50.6 / 100 HOLD
Tech 38.0 Fund 64.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BOLD +101.74% IMMX +64.54% Spread: +37.2 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BOLD TTM Op. Margin: 0.0% IMMX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs IMMX. Trailing 12-month operating profitability (BOLD 0.0% vs IMMX 0.0%) and valuation multiples (BOLD N/M vs IMMX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BOLD (2) vs IMMX (3)
Institutional Metric BOLD IMMX Criterion Row Winner
Market Capitalization Scale $56.2M $590.0M Larger Scale IMMX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -64.6% -27.0% Higher ROE IMMX
52-Week Range Position Momentum 62% ($1โ€“$3) 28% ($4โ€“$15) Stronger Trend BOLD
Beta / 30D Volatility Risk Regime -0.08ฮฒ ยท 28% Vol 1.65ฮฒ ยท 76% Vol Lower Realized Risk BOLD
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 50.6 / 100 (HOLD) Higher Composite IMMX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BOLD vs IMMX Buy Guide
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMMX BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live IMMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BOLD nor IMMX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.